Matches in Wikidata for { <http://www.wikidata.org/entity/Q93020840> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q93020840 description "2018 թվականի նոյեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q93020840 description "article scientifique publié en 2018" @default.
- Q93020840 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93020840 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93020840 description "scientific article published on 12 November 2018" @default.
- Q93020840 description "wetenschappelijk artikel" @default.
- Q93020840 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93020840 name "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 name "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 type Item @default.
- Q93020840 label "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 label "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 prefLabel "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 prefLabel "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 P1433 Q93020840-2CDE2422-C06B-4BE5-8ABB-2C39982010C5 @default.
- Q93020840 P1476 Q93020840-40BD59F3-3DC1-4859-89B5-0E2E208E95C6 @default.
- Q93020840 P2093 Q93020840-8AE4E8AA-C977-4C35-B861-C53A24C9F642 @default.
- Q93020840 P2093 Q93020840-A4B47C16-AB78-40DA-A154-15C24F1D7587 @default.
- Q93020840 P2093 Q93020840-AF91DC54-83F7-48D7-ACAD-3610B47EDF8C @default.
- Q93020840 P2093 Q93020840-C7FBEC74-8CAC-4BBC-863D-6F88E1453BC5 @default.
- Q93020840 P304 Q93020840-A157CD75-51FE-42A4-A9AF-B8D090BC0966 @default.
- Q93020840 P31 Q93020840-2B6125E6-26B0-47C9-8E92-5FB8BF298950 @default.
- Q93020840 P356 Q93020840-32F7949C-82B1-41DC-9DE8-4824FD64AEDE @default.
- Q93020840 P433 Q93020840-8E6C21A1-7401-49FC-984D-3D6F54F412B3 @default.
- Q93020840 P478 Q93020840-B8339B80-216C-41B6-A1F0-DAE9D07BE47C @default.
- Q93020840 P50 Q93020840-43281387-AF6A-408A-83B4-DB251538C7F7 @default.
- Q93020840 P577 Q93020840-B6970A6B-B5C3-48E6-9A4E-44E433D68F7E @default.
- Q93020840 P698 Q93020840-90C0FD02-EDB3-4075-A073-A375BEC1CF5B @default.
- Q93020840 P921 Q93020840-1144A3B3-C3CE-4FEE-9AA4-F1ABC77EF577 @default.
- Q93020840 P921 Q93020840-19CCC4E1-274C-4142-B7A1-35AA3F27DE1B @default.
- Q93020840 P921 Q93020840-7740876A-DDDE-4887-B986-DC4777A5F7B0 @default.
- Q93020840 P356 S10067-018-4327-4 @default.
- Q93020840 P698 30421069 @default.
- Q93020840 P1433 Q15754927 @default.
- Q93020840 P1476 "Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial" @default.
- Q93020840 P2093 "Francesca Nacci" @default.
- Q93020840 P2093 "Laura Bazzichi" @default.
- Q93020840 P2093 "Laura Bianchino" @default.
- Q93020840 P2093 "Luigi Sinigaglia" @default.
- Q93020840 P304 "841-849" @default.
- Q93020840 P31 Q13442814 @default.
- Q93020840 P356 "10.1007/S10067-018-4327-4" @default.
- Q93020840 P433 "3" @default.
- Q93020840 P478 "38" @default.
- Q93020840 P50 Q79765409 @default.
- Q93020840 P577 "2018-11-12T00:00:00Z" @default.
- Q93020840 P698 "30421069" @default.
- Q93020840 P921 Q187255 @default.
- Q93020840 P921 Q425154 @default.
- Q93020840 P921 Q6934595 @default.